ReviewMedicine2025
Research hotspots and emerging topics in neuromyelitis optica spectrum disorder treatment: Insights from a bibliometric analysis.
Review in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectEffective treatment of neuromyelitis optica spectrum disorder (NMOSD) can greatly reduce the rate of disability and mortality among patients. NMOSD treatment studies are gaining prominence in academic circles. This study aims to depict the evolution and integration of NMOSD treatment over the past 20 years, identify key contributors in the field, clarify current research hotspots, and explore emerging topics that may guide future research directions.
methodArticles in this field from 2004 to 2023 were collected from the Web of Science Core Collection (WoSCC). After conducting a literature search, a comprehensive bibliometric and knowledge mapping analysis was carried out on the retrieved articles using tools such as VOSviewer, Bibliometrix, and CiteSpace.
resultThe rapid growth in annual publications in this field indicates rapid progress and innovation. USA, Mayo Clinic, and Fujihara K led in productivity and impact, while the multiple sclerosis and related disorders topped in publication volume. The research hotspots in this field mainly focus on targeted biological agents. Additionally, this study has identified 3 emerging themes and conducted an in-depth exploration of their future development trends.
conclusionIn summary, this bibliometric analysis provides for the first time a comprehensive framework and frontier hot spot analysis in the field of NMOSD treatment, offering references for researchers in the field and contributing to the further development of the field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.